Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to more than 4 million confirmed infections worldwide and over 300,000 deaths. While Remdesivir has recently received FDA emergency use authorization for treatment of SARS-CoV-2 infection, convalescent plasma (CP) with high titers...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:medRxiv
Autors principals: Danh, Kenneth, Karp, Donna Grace, Robinson, Peter V., Seftel, David, Stone, Mars, Simmons, Graham, Bagri, Anil, Schreiber, Martin, Buser, Andreas, Holbro, Andreas, Battegay, Manuel, Corash, Laurence M., Hanson, Carl, Tsai, Cheng-ting
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7302305/
https://ncbi.nlm.nih.gov/pubmed/32577696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.28.20105692
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars